Business & Industry
Eli Lilly to Acquire Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly & Co. is set to acquire Centessa Pharmaceuticals Plc in a transaction worth up to $7.8 billion, underscoring its push to broaden its drug development pipeline. The Centessa Pharmaceuticals deal highlights the company’s effort to expand into therapeutic...
News
D2 Solutions Highlights Medication Access Delays in U.S.
New findings from healthcare consulting and technology company D2 Solutions indicate that medication access delays are influencing whether patients initiate prescribed therapies, with confusion and administrative hurdles emerging as key barriers. Based on a survey of 1,000 U.S. adults...
Business & Industry
Johnson & Johnson Wins DARZALEX Self-Administration EU Nod
Johnson & Johnson has received a key regulatory endorsement in Europe, marking a significant shift in how oncology treatments can be administered. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has approved a...
Business & Industry
Transcend Acquisition Advances Otsuka Neuroplastogen Focus
Japanese pharmaceutical company Otsuka has moved to deepen its presence in the emerging neuroplastogen space through an agreement to acquire Transcend Therapeutics, bringing with it a promising MDMA-based candidate targeting post-traumatic stress disorder (PTSD) and related psychiatric conditions. The...
Business & Industry
Novartis $2bn Excellergy Acquisition Boosts Allergy Pipeline
Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its pipeline. Excellergy acquisition is structured at up to $2bn in upfront and milestone payments and...
News
The Private Practice Advantage: Improving Access to Orthopedic Care for Faster Pain Relief
As a life sciences leader, you are uniquely positioned to bridge the gap between innovation and implementation, but the journey to the patient can appear fragmented within traditional hospital systems. For orthopedics, the private practice model has become a...
News
The Importance of Controlled Exposure Simulation in Modern Laboratories
Regulatory expectations across the life sciences industries are changing, with more focus on clear and measurable exposure data. Starting from early-stage drug development through to large-scale manufacturing, you are expected to show how chemical, biological and physical agents may...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read